COVID-19 Impact on Sexually Transmitted Diseases Testing Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Sexually Transmitted Diseases Testing Industry
1.7 COVID-19 Impact: Sexually Transmitted Diseases Testing Market Trends
2 Global Sexually Transmitted Diseases Testing Quarterly Market Size Analysis
2.1 Sexually Transmitted Diseases Testing Business Impact Assessment - COVID-19
2.1.1 Global Sexually Transmitted Diseases Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Sexually Transmitted Diseases Testing Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Sexually Transmitted Diseases Testing Quarterly Market Size, 2019 VS 2020
3.2 By Players, Sexually Transmitted Diseases Testing Headquarters and Area Served
3.3 Date of Key Players Enter into Sexually Transmitted Diseases Testing Market
3.4 Key Players Sexually Transmitted Diseases Testing Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Sexually Transmitted Diseases Testing Segments, By Type
4.1 Introduction
1.4.1 Chlamydia Testing
1.4.2 Gonorrhea Testing
1.4.3 Syphilis Testing
1.4.4 HIV Testing
1.4.5 HSV Testing
1.4.6 HPV Testing
1.4.7 Chancroid Testing
1.4.8 Other
4.2 By Type, Global Sexually Transmitted Diseases Testing Market Size, 2019-2021
5 Impact of Covid-19 on Sexually Transmitted Diseases Testing Segments, By Application
5.1 Overview
5.5.1 Clinics
5.5.2 Hospitals
5.5.3 Other
5.2 By Application, Global Sexually Transmitted Diseases Testing Market Size, 2019-2021
5.2.1 By Application, Global Sexually Transmitted Diseases Testing Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 BioMerieux
7.1.1 BioMerieux Business Overview
7.1.2 BioMerieux Sexually Transmitted Diseases Testing Quarterly Revenue, 2020
7.1.3 BioMerieux Sexually Transmitted Diseases Testing Product Introduction
7.1.4 BioMerieux Response to COVID-19 and Related Developments
7.2 F. Hoffmann La Roche
7.2.1 F. Hoffmann La Roche Business Overview
7.2.2 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Quarterly Revenue, 2020
7.2.3 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Product Introduction
7.2.4 F. Hoffmann La Roche Response to COVID-19 and Related Developments
7.3 BD
7.3.1 BD Business Overview
7.3.2 BD Sexually Transmitted Diseases Testing Quarterly Revenue, 2020
7.3.3 BD Sexually Transmitted Diseases Testing Product Introduction
7.3.4 BD Response to COVID-19 and Related Developments
7.4 Abbott
7.4.1 Abbott Business Overview
7.4.2 Abbott Sexually Transmitted Diseases Testing Quarterly Revenue, 2020
7.4.3 Abbott Sexually Transmitted Diseases Testing Product Introduction
7.4.4 Abbott Response to COVID-19 and Related Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Business Overview
7.5.2 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Quarterly Revenue, 2020
7.5.3 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Product Introduction
7.5.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.6 Abbott
7.6.1 Abbott Business Overview
7.6.2 Abbott Sexually Transmitted Diseases Testing Quarterly Revenue, 2020
7.6.3 Abbott Sexually Transmitted Diseases Testing Product Introduction
7.6.4 Abbott Response to COVID-19 and Related Developments
7.7 Qiagen
7.7.1 Qiagen Business Overview
7.7.2 Qiagen Sexually Transmitted Diseases Testing Quarterly Revenue, 2020
7.7.3 Qiagen Sexually Transmitted Diseases Testing Product Introduction
7.7.4 Qiagen Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Sexually Transmitted Diseases Testing Assessment
Table 9. COVID-19 Impact: Sexually Transmitted Diseases Testing Market Trends
Table 10. COVID-19 Impact Global Sexually Transmitted Diseases Testing Market Size
Table 11. Global Sexually Transmitted Diseases Testing Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Sexually Transmitted Diseases Testing Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Sexually Transmitted Diseases Testing Market Growth Drivers
Table 14. Global Sexually Transmitted Diseases Testing Market Restraints
Table 15. Global Sexually Transmitted Diseases Testing Market Opportunities
Table 16. Global Sexually Transmitted Diseases Testing Market Challenges
Table 17. By Players, Sexually Transmitted Diseases Testing Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Sexually Transmitted Diseases Testing Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Sexually Transmitted Diseases Testing Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Sexually Transmitted Diseases Testing Market
Table 21. Key Players Sexually Transmitted Diseases Testing Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Sexually Transmitted Diseases Testing Market Size 2019-2021, (US$ Million)
Table 24. Global Sexually Transmitted Diseases Testing Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Sexually Transmitted Diseases Testing Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Sexually Transmitted Diseases Testing Market Size, 2019-2021 (US$ Million)
Table 57. BioMerieux Business Overview
Table 58. BioMerieux Sexually Transmitted Diseases Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. BioMerieux Sexually Transmitted Diseases Testing Product
Table 60. BioMerieux Response to COVID-19 and Related Developments
Table 61. F. Hoffmann La Roche Business Overview
Table 62. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Product
Table 64. F. Hoffmann La Roche Response to COVID-19 and Related Developments
Table 65. BD Business Overview
Table 66. BD Sexually Transmitted Diseases Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. BD Sexually Transmitted Diseases Testing Product
Table 68. BD Response to COVID-19 and Related Developments
Table 69. Abbott Business Overview
Table 70. Abbott Sexually Transmitted Diseases Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Abbott Sexually Transmitted Diseases Testing Product
Table 72. Abbott Response to COVID-19 and Related Developments
Table 73. Bio-Rad Laboratories Business Overview
Table 74. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Product
Table 76. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 77. Abbott Business Overview
Table 78. Abbott Sexually Transmitted Diseases Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Abbott Sexually Transmitted Diseases Testing Product
Table 80. Abbott Response to COVID-19 and Related Developments
Table 81. Qiagen Business Overview
Table 82. Qiagen Sexually Transmitted Diseases Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Qiagen Sexually Transmitted Diseases Testing Product
Table 84. Qiagen Response to COVID-19 and Related Developments
List of FiguresFigure 1. Sexually Transmitted Diseases Testing Product Picture
Figure 2. Sexually Transmitted Diseases Testing Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Sexually Transmitted Diseases Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Sexually Transmitted Diseases Testing Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Sexually Transmitted Diseases Testing Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Sexually Transmitted Diseases Testing Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Sexually Transmitted Diseases Testing Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Sexually Transmitted Diseases Testing Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Sexually Transmitted Diseases Testing Market Size Market Share, 2019-2021